Rates of latent tuberculosis in health care staff in Russia

PLoS Medicine

Volumn 4, Issue 2, 2007, Pages 0273-0279

  Drobniewski, Francis ^a   Balabanova, Yanina ^a,b   Zakamova, Elena ^b   Nikolayevskyy, Vladyslav ^a   Fedorin, Ivan ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Samara Oblast Tuberculosis Dispensary   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXPOSURE VARIABLE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL STUDENT; NURSE; PHYSICIAN; PREVALENCE; QUESTIONNAIRE; RATING SCALE; RISK ASSESSMENT; RUSSIAN FEDERATION; TUBERCULOSIS; TUBERCULOSIS CONTROL; ADOLESCENT; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; MIDDLE AGED; RETROSPECTIVE STUDY; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PERSONNEL; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RUSSIA; SOCIOECONOMIC FACTORS; TUBERCULOSIS;

EID: 33847608416     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040055     Document Type: Article

References (24)

1. Tufariello JM, Chan J, Flynn JL (2003) Latent tuberculosis: Mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 3: 578-590.
2. Spradling P, Nemtsova E, Aptekar T, Shulgina M, Rybka L, et al. (2002) Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation. Int J Tuberc Lung Dis 6: 757-762.
3. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, et al. (2005) Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 60: 130-135.
4. Drobniewski F, Balabanova Y, Nikolayevskyy V, Ruddy M, Kuznetzov S, et al. (2005) Drug resistant tuberculosis, clinical virulence and the dominance of the Beijing strain family in Russia. JAMA 293: 2726-2731.
5. Ministry of Health, Russian Federation (2003) On improvement of TB control activities in the Russian Federation. Prikaz number 109. Moscow: Ministry of Health. 150 p
6. Dimitrova B, Hutchings A, Atun R, Drobniewski F, Marchenko G, et al. (2005) Increased risk of tuberculosis among health care workers in Samara Oblast, Russia: Analysis of notification data. Int J Tuberc Lung Dis 9: 43-48.
7. Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356: 1099-1104.
8. Pai M, Kalantri S, Dheda K (2006) New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 6: 423-432.
9. Lalvani A (2004) Counting antigen-specific T cells: A new approach for monitoring response to tuberculosis treatment? Clin Infect Dis 38: 757-759.
10. Dheda K, Chang JS, Kim LU, Huggett JF, Johnson MA, et al. (2005) Interferon gamma assays for tuberculosis. Lancet Infect Dis 5: 324-325; author reply 325-327.
11. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, et al. (2001) Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357: 2017-2021.
12. Lalvani A, Richeldi L, Kunst H (2005) Interferon gamma assays for tuberculosis. Lancet Infect Dis 5: 322-4; author reply 325-327.
13. Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, et al. (2001) Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 286: 1740-1747.
14. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, et al. (2004) Specific detection of tuberculosis infection: An interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170: 59-64.
15. Whalen CC (2005) Diagnosis of latent tuberculosis infection: Measure for measure. JAMA 293: 2785-2787.
16. Drobniewski FA, Tayler E, Ignatenko N, Paul J, Connolly M, et al. (1996) TB in Siberia 2- diagnosis, chemoprophylaxis and treatment. Tuber Lung Disease 77: 297-301.
17. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, et al. (2005) Mycobacterium tuberculosis infection in health care workers in rural India: Comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 293: 2746-2755.
18. Pai S, Esen N, Pan X, Musser JM (1997) Routine rapid Mycobacterium species assignment based on species-specific allelic variation in the 65-kilodalton heat shock protein gene (hsp65). Arch Pathol Lab Med 121: 859-864.
19. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, et al. (2006) Serial testing of health care workers for tuberculosis using interferon-γ assay. Am J Respir Crit Care Med 174: 349-355.
20. American Thoracic Society and the Centers for Disease Control and Prevention (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161: S221-247.
21. World Health Organization/ International Union Against Tuberculosis and Lung Disease (WHO/IUALTD) Global Project on Anti-Tuberculosis Drug Surveillance (2004) Anti-tuberculosis drug resistance in the world: Third global report/the WHO/IUALTD Global Project on Anti-Tuberculosis Drug Surveillance, 1999-2002. Publication WHO/HTM/TB/2004.343. Geneva: World Health Organization. 299 p.
22. Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, et al. (2004) Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis 8: 598-602.
23. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, et al. (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54: 49-55
24. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, et al. (2002) Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 40: 704-706.